The 2020 Award of 50’000.00 Swiss Francs has been granted on May 8, 2021 in Lugano to
Prof. Dr. Radek C. Skoda
in recognition for his contribution to the understanding of the molecular pathogenesis of myeloproliferative neoplasms.
Radek Skoda is Professor of Molecular Medicine and Chair, Department of Biomedicine, University of Basel and University Hospital of Basel, Switzerland.
Radek Skoda obtained his medical diploma 1981 in Zürich and his doctoral degree 1983 working in the Department of Biochemistry of the University of Zürich. After this he moved to Basel where his career started as postdoctoral fellow at the Biozentrum. In 1993 he became group leader at the Biozentrum, then moved to the German Cancer Research Center as Head, “Molecular Hematology-Oncology”, in 2000 and came back to Basel in his current position in 2002.
His research group on experimental hematology studies the molecular pathogenesis of myeloproliferative neoplasm that represent clonal stem cell disorders with a tendency towards transformation into leukemia. Myeloproliferative disorders are characterized by aberrant proliferation of precursors of the myeloid, erythroid and megakaryocytic lineages resulting in elevated blood counts of neutrophilic granulocytes, red cells and platelets. The discovery of mutations of the Janus kinase 2 (JAK2) gene by Prof. Radek has been a key in the understanding of the molecular nature of these disorders, leading the way to further discoveries on the role of mutations of calreticulin, thrombopoietin receptor and epigenetic regulators of signaling proteins, as well as the introduction of selective novel therapies in the clinical setting.
Radek Skoda has authored and co-authored over 150 articles, reviews and book chapters.
He is a member of the American Society of Hematology, the Swiss Society of Hematology and the European Hematology Association. He has served as chair or co-chair of numerous international scientific and educational events. In 2013 he was elected to the Swiss Academy of Medical Sciences.
Among other awards, Radek Skoda has been distinguished with the Research Prize of the Cloetta Foundation in 2004 and the David Grimwade Award 2020 of the European Hematology Association.